Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1229-1234

  Suzuki, Yoshiyuki ^a,b   Nakano, Takashi ^a   Arai, Tatsuo ^a   Morita, Shinroku ^a   Tsujii, Hirohiko ^a   Oka, Kuniyuki ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Mito Saiseikai General Hospital   (Japan)

Author keywords

Adenocarcinoma; Estrogen receptor; Progesterone receptor; Radiation therapy; Uterine cervix

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0034661777     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00495-8     Document Type: Article

References (24)

1. Brand E., Berek J.S., Hacker N.F. Controversies in the management of cervical adenocarcinoma. Obstet Gynecol. 71:1988;261-269.
2. Kleine W., Rau K., Schwoeorer D., et al. Prognosis of the adenocarcinoma of the cervix uteri A comparative study . Gynecol Oncol. 35:1989;145-149.
3. Eifel P.J., Morris M., Oswald M.J., et al. Adenocarcinoma of the uterine cervix Prognosis and patterns of failure in 367 cases . Cancer. 65:1990;2507-2514.
4. Silcocks P.B.S., Thornton-Jones H., Murphy M. Squamous and adenocarcinoma of the uterine cervix A comparison using routine data . Br J Cancer. 55:1987;321-325.
5. Leminen A., Paavonen J., Forss M., et al. Adenocarcinoma of the uterine cervix. Cancer. 65:1990;53-59.
6. Chen R.J., Chang D.Y., Yen M.L., et al. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol. 69:1998;157-164.
7. Sanborn B.N., Held B., Kuo H.S. Specific estrogen binding proteins in human cervix. J Steroid Biochem. 6:1975;1107-1112.
8. Sanborn B.N., Held B., Kuo H.S. Hormone action in human cervix II. Specific progesterone binding proteins in human cervix . J Steroid Biochem. 7:1976;665-672.
9. Masood S., Rhatigan R.M., Wilkinson E.W., et al. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix An immunocytochemical study . Cancer. 72:1993;511-518.
10. Fujiwara H., Tortolero-Luna G., Mitchell M.F., et al. Adenocarcinoma of the cervix. Cancer. 79:1997;505-512.
11. Clark G.M., McGuire W.L., Hubay C.A., et al. Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med. 309:1983;1343-1347.
12. Fukuda K., Mori M., Uchiyama M., et al. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol. 69:1998;220-225.
13. Kommoss F., Pfisterer J., Thome M., et al. Steroid receptors in ovarian carcinoma Immunohistochemical determination may lead to new aspects . Gynecol Oncol. 47:1992;317-322.
14. Bizzi A., Codegoni A.M., Landoni F., et al. Steroid receptors in epthelial ovarian carcinoma Relation to clinical parameters and survival . Cancer Res. 48:1988;6222-6226.
15. Chambers J.J., Maclusky N., Eisenfield A., et al. Estrogen and progestin receptor levels as prognostic factors for survival in endometrial cancer. Gynecol Oncol. 31:1988;65-77.
16. McGuire W.L. Estrogen receptors in human breast cancer. J Clin Invest. 52:1973;73-77.
17. Arai T., Nakano T., Morita S., et al. High dose rate remote after-loading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 69:1992;175-180.
18. Nakano T., Arai T., Morita S., et al. Radiation therapy alone for adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 32:1995;1331-1336.
19. Arai T., Morita S., Kutsutani Y., et al. Special report no. 17. Br J Radiol. 18:1978;89-92.
20. Ghandour F.A., Attanoos R., Nahar K., et al. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology. 24:1994;49-55.
21. 1. Cancer Res. 54:1994;1587-1595.
22. Paulsen G.H.U., Strickert T., Marthinsen A.B.L., et al. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol. 35:1996;1011-1019.
23. Scambia G., Panici P.B., Baiocchi G., et al. Steroid hormone receptors in carcinoma of the cervix Lack of response to an antiestrogen . Gynecol Oncol. 37:1990;323-326.
24. Greman R., Virolaine E., Shapira A., et al. In vivo effects of tamoxifen on UM-SCC head and neck cancer cell lines Correlation with the estrogen and progesterone receptor content . Int J Cancer. 39:1987;77-81.